H-CYTE (OTCMKTS:HCYTD – Get Free Report) and Penumbra (NYSE:PEN – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, risk, earnings, profitability and valuation. Analyst Ratings This is a summary of recent ratings and […]
H-CYTE, Inc. (OTCMKTS:HCYTD – Get Rating) shares fell 49.5% on Tuesday . The stock traded as low as $2.02 and last traded at $2.02. 400 shares changed hands during trading, an increase of 288% from the average session volume of 103 shares. The stock had previously closed at $4.00. H-CYTE Stock Down 49.5 % The […]
H-CYTE, Inc. (OTCMKTS:HCYT – Get Rating) saw a significant drop in short interest during the month of May. As of May 31st, there was short interest totalling 1,400 shares, a drop of 74.1% from the May 15th total of 5,400 shares. Based on an average daily trading volume, of 150,000 shares, the days-to-cover ratio is […]
H-CYTE, Inc. (OTCMKTS:HCYT – Get Rating) saw a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 5,400 shares, an increase of 22.7% from the April 30th total of 4,400 shares. Based on an average daily trading volume, of 195,300 shares, the short-interest ratio is […]
H-CYTE (OTCMKTS:HCYT – Get Rating) and ICU Medical (NASDAQ:ICUI – Get Rating) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, risk, institutional ownership, earnings and analyst recommendations. Risk & Volatility H-CYTE has a beta of 0.99, indicating that […]